Vivus

3 Stories

FDA Greenlights 2nd Weight-Loss Drug

Qsymia the more effective of the pair in clinical trials

(Newser) - After 13 years without approving a new weight-loss drug, the FDA has now approved two within three weeks. After June's approval of Belviq , the FDA yesterday approved Qsymia, which used to be called Qnexa ; both drugs had previously been rejected. In studies, Qsymia resulted in the greater weight loss:...

FDA OKs Viagra Rival: It Works Twice as Fast

Maker Vivus says Stendra provides erections in 15 minutes

(Newser) - Viagra just got some more competition: The FDA today approved the drug Stendra, which promises to provide an erection in 15 minutes, roughly twice as fast as the minimum wait time for Viagra, reports Bloomberg . Its analysts expect Vivus to pull in nearly $70 million in sales next year. By...

First Diet Drug in 13 Years? FDA to Start Review

Qnexa will be reviewed by the agency next week

(Newser) - If the FDA gives its blessing, a drug named Qnexa could become a very big deal. A preliminary review begins next week on the pill, which could become the first diet drug approved in 13 years, reports the New York Times . It's nowhere near a sure thing: Two years...

3 Stories
Most Read on Newser